Literature DB >> 29129198

Corticotropin-Releasing Factor Type 1 Receptor Antagonists for Stress-Related Disorders: Time to Call It Quits?

James W Murrough1, Dennis S Charney2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29129198     DOI: 10.1016/j.biopsych.2017.10.012

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  6 in total

Review 1.  Translating Molecular and Neuroendocrine Findings in Posttraumatic Stress Disorder and Resilience to Novel Therapies.

Authors:  Jonathan DePierro; Lauren Lepow; Adriana Feder; Rachel Yehuda
Journal:  Biol Psychiatry       Date:  2019-07-24       Impact factor: 13.382

Review 2.  A way forward for anxiolytic drug development: Testing candidate anxiolytics with anxiety-potentiated startle in healthy humans.

Authors:  Christian Grillon; Monique Ernst
Journal:  Neurosci Biobehav Rev       Date:  2020-10-07       Impact factor: 8.989

3.  Corticotropin-Releasing Hormone Binding Protein: Stress, Psychopathology, and Antidepressant Treatment Response.

Authors:  Ned H Kalin
Journal:  Am J Psychiatry       Date:  2018-03-01       Impact factor: 18.112

Review 4.  Sex differences in the hypothalamic-pituitary-adrenal axis: An obstacle to antidepressant drug development?

Authors:  Nikolaos Kokras; Georgia E Hodes; Debra A Bangasser; Christina Dalla
Journal:  Br J Pharmacol       Date:  2019-06-26       Impact factor: 8.739

Review 5.  Neurochemical mechanisms and neurocircuitry underlying the contribution of stress to cocaine seeking.

Authors:  Aaron Caccamise; Erik Van Newenhizen; John R Mantsch
Journal:  J Neurochem       Date:  2021-03-22       Impact factor: 5.546

6.  Considering Sex as a Biological Variable in Basic and Clinical Studies: An Endocrine Society Scientific Statement.

Authors:  Aditi Bhargava; Arthur P Arnold; Debra A Bangasser; Kate M Denton; Arpana Gupta; Lucinda M Hilliard Krause; Emeran A Mayer; Margaret McCarthy; Walter L Miller; Armin Raznahan; Ragini Verma
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 25.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.